In the case of GC patients and healthy volunteers ≤50 years, statistically significant changes did not concern the percentage of TLR-3 on BDCA-1 and BDCA-2; TLR-3 and TLR-9 on classical monocytes (Table 3). This evidence concerns the gene TLR9 and gastric cancer.